Novartis keeps CEO pay steady, but incoming chairman pay drops
BASEL (Reuters) - Novartis kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards.
Related Articles
- 2011 Annual Corporate Governance Review — The Harvard Law School Forum on Corporate Governance and Financial Regulation also categorized in BoardNews
- NACD BoardVision - NACD BoardVision – “The role of the board as company spokesperson” - Resources - NACD also categorized in BoardNews
- Boardmember.com's 10 Most Viewed Articles of 2011 also categorized in BoardNews
- Coca-Cola Faces Renewed Pressure Over Executive Pay also written by Reuters
- Still few women on boards also categorized in BoardNews
- What Boards Should Know About Social Media also categorized in BoardNews
- Lululemon Has A New CEO also written by Reuters
- A Changed and Changing Executive Compensation Environment also mentions Executive Compensation
- Corporate Governance Best Practices also categorized in BoardNews
- Exclusive: IBM hired advisers to deal with restless investors - sources also written by Reuters
Login to comment.